Types segmentation categorizes medical dural patches into synthetic, biological, and composite variants, each influencing market dynamics through distinct performance attributes and regulatory considerations. Synthetic patches, typically fabricated from polymers such as polytetrafluoroethylene or polyurethane, offer uniform thickness, predictable tensile strength, and extended shelf life, making them attractive for high‑volume neurosurgical settings. Biological patches, derived from autologous, allogeneic, or xenogeneic collagen matrices, provide inherent biocompatibility and promote tissue integration, thereby commanding premium pricing in complex cranial reconstructions. Composite patches combine synthetic scaffolds with biologically active layers, aiming to balance mechanical durability with enhanced healing, and are increasingly adopted in spinal procedures where both strength and bioactivity are critical. The proportional adoption of each type is shaped by clinical outcomes data, cost‑effectiveness analyses, and surgeon preference, collectively shaping the market’s total addressable value. Understanding this taxonomy is essential for stakeholders seeking to align product pipelines with evolving clinical demand.
